
Fabio Arcidiacono
@fabarcidiacono8
Radiation Oncologist, S.Maria Hospital, Terni
ID: 1598343210543316992
01-12-2022 15:50:32
1,1K Tweet
307 Followers
294 Following

ESTRO25: What’s Happening on Day 2 ESTRO Fabio Arcidiacono | Alizée Camps - - Maléa | Elisabetta Bonzano MD, PhD | Giulia Marvaso | Giulio Francolini | Gerard Walls | George E. Naoum, MD | George E. Naoum, MD | Ane Appelt | Tom Roques | Ben Slotman | Pierre Blanchard, MD | Donjeta Zeqa | Matteo Lambertini, MD PhD |



Fabio Arcidiacono ESTRO Radiotherapy & Oncology Stefano Arcangeli Giulio Francolini Federica Ferrario Giulia Marvaso prof. Barbara Jereczek-Fossa We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing! oncodaily.com/blog/fabio-arc…

C. Jillian Tsai, MD, PhD Drew Moghanaki Percy Lee MD START-NEW-ERA also provides some interesting context to this conversation! Fabio Arcidiacono

C. Jillian Tsai, MD, PhD Drew Moghanaki Percy Lee MD Fabio Arcidiacono Such an abbreviated treatment regimen would greatly benefit the people of West Virginia. I am convinced we have the worst transport issues of any state. I hope we run such a trial in the United States, as we’d have a robust population that may benefit. ers.usda.gov/sites/default/…


Jeff Ryckman This is wonderful. Congrats Fabio Arcidiacono for your excellent work. A lot of information to digest. Is the protocol available and will be paper be out soon?


Fabio Arcidiacono Jeff Ryckman Paola Anselmo Gustavo Can't wait to see the results!





Prof. Shankar Siva reminds us that SAFRON II was a “SABR in lieu of systemic therapy” study for patients with lung metastases. #SABRCAN25


If you’re curious what Shankar Siva is up to next, say hello to the recently funded phase III randomized PRIME-LUNG study (n=420). #SABRCAN25


